HOME >> BIOLOGY >> NEWS
Common cancer gene sends death order to tiny killer

Scientists at Johns Hopkins have discovered one way the p53 gene does what it's known forstopping the colon cancer cells. Their report will be published in the June 8 issue of Molecular Cell.

The research team identified a tiny bit of genetic code, a microRNA called miR-34a that participates in p53's uncanny ability to kill cells likely to become malignant because of damaged genes in their nuclei. MicroRNAs are small chains of ribonucleic acid (RNA) made by the same machinery that produces other types of RNA in the cell, such as the messenger RNAs that carry the instructions to make proteins. Once produced, microRNAs stick to messenger RNAs and, like crumpled paper jammed in a copy machine, prevent proteins from being made.

Josh Mendell, M.D., Ph.D., an assistant professor in the McKusick-Nathans Institute of Genetic Medicine, suspected that p53 activates microRNAs like miR-34a because a number of studies have demonstrated that these tiny RNA molecules are frequently abnormal in cancer cells.

"P53 is one of the most commonly mutated genes in human cancers," says Mendell. "And there is now a great deal of evidence that microRNAs themselves can act to either promote cancer or to stop cancer spread."

To test their idea, the team first chemically damaged the DNA of two sets of colon cancer cells, one missing p53 and the other containing healthy p53. They then looked for any of the 500 known human microRNAs that are activated only in cells containing p53.

It turned out that the miR-34a gene is turned on by p53, and in fact, experiments demonstrated that p53 binds directly to the genetic material near miR-34a to promote its activation.

Concluding that p53 controls miR-34a, they next teamed up with Charlie Lowenstein, M.D., and his colleagues in Hopkins's department of medicine to put miR-34a into colon cancer cells. Doing this killed cells that contained p53, but fewer were killed in cells lacking p53, furt
'"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
31-May-2007


Page: 1 2

Related biology news :

1. Common environmental chemicals in diet affect fetal ovarian development
2. Common treatment for methamphetamine overdose may damage brain cells
3. Common genetic variation is linked to substantial risk for heart attack
4. Common fungicide causes long-term changes in mating behavior
5. DNA ends: Common tool, different job
6. Common gene version optimizes thinking -- but with a possible downside
7. Common mechanisms for viral DNA replication
8. Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia
9. Common cause of heart disease, diabetes may be treatable with malaria drug
10. Commonplace sugar compound silences seizures
11. Common garden plant threatened by climate change

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine ... ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, ... UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A ...
(Date:10/29/2019)... ... October 29, 2019 , ... Fujirebio Diagnostics, Inc., a ... (FDA) clearance of the company’s Lumipulse® G whole PTH Assay for testing on ... by the parathyroid glands; which are four small glands located behind the thyroid ...
(Date:10/26/2019)... ... October 23, 2019 , ... Nanovis today announced that ... the FDA requirements for nanotechnology. , “We are delighted to receive such ... important role in achieving Nanovis’ goal to reduce the pain and suffering from ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... Diversified Technologies, Inc. has ... and vegetables per hour to improve processing. , The DTI Industrial PEF Unit can ... hour to increase juice yields by up to 50% and achieve up to an ...
(Date:11/2/2019)... (PRWEB) , ... October 31, 2019 , ... ... not always used to communicating with each other: study managers, principal investigators, supply ... misunderstandings if a party is not informed of the latest data, potentially leading ...
(Date:10/29/2019)... Conn. (PRWEB) , ... October 28, 2019 , ... ... Advisory Board: , , Professor Jack R Wands, MD, of ... and Wyeth (Pfizer) , Professor Gil Mor, MD, PhD, of Wayne State ...
(Date:10/22/2019)... N.J. (PRWEB) , ... October 22, 2019 , ... Catalent, ... Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session ... Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. ...
Breaking Biology Technology:
Cached News: